Why Aren't Alzheimer's Medications Usually Used for FTD?

When a family receives a dementia diagnosis, it is natural to expect a prescription for common memory medications like donepezil (Aricept), rivastigmine (Exelon), galantamine (Razadyne), or memantine (Namenda). While these are standard treatments for Alzheimer’s disease, they are generally not recommended for Frontotemporal Dementia (FTD). Doctors typically avoid these medications in FTD because the diseases affect the brain differently. These drugs have not been shown to provide meaningful benefit for FTD, and some of them may worsen certain behavioral symptoms.

Different Brain Chemistry: Why They Are Not Recommended

FTD is a clinical syndrome with multiple potential causes, but it generally does not involve the same prominent chemical deficits seen in Alzheimer’s disease ^[1][2]. Because the underlying biology is different, Alzheimer’s medications do not provide the same temporary symptom relief in FTD ^[3].

• Cholinesterase Inhibitors (donepezil, rivastigmine, galantamine): In Alzheimer’s, memory loss is largely driven by a loss of acetylcholine, a chemical messenger crucial for learning. These drugs temporarily boost acetylcholine levels for symptomatic benefit ^[1]. Because FTD is instead driven by the buildup of different proteins (like TDP-43, tau, or FUS) in the frontal and temporal lobes, acetylcholine-producing cells are usually preserved ^[1][4]. As a result, boosting acetylcholine does not improve FTD symptoms ^[3][2].
• Memantine (Namenda): This medication works through a completely different mechanism (regulating a chemical called glutamate). However, just like cholinesterase inhibitors, clinical trials of memantine have not demonstrated meaningful cognitive or functional benefit in FTD, leading experts to recommend avoiding it as a routine treatment ^[5][2].

The Risk of Worsening Behavioral Symptoms

Taking Alzheimer’s medications when you have FTD, particularly the behavioral variant (bvFTD), can sometimes cause adverse effects. While memantine has not been shown to carry the same behavioral risks, cholinesterase inhibitors like donepezil can worsen agitation, disinhibition, and compulsive behaviors in some patients ^[6][2].

In a small clinical study, some FTD patients taking donepezil experienced an increase in disinhibited and impulsive behaviors ^[6]. The exact reason for this worsening remains uncertain, but it highlights why doctors are cautious. Fortunately, in the study, these worsened behavioral symptoms improved after the medication was discontinued ^[6]. Aside from behavioral changes, cholinesterase inhibitors can also cause physical side effects like nausea, diarrhea, sleep disturbances, dizziness, and a slowed heart rate ^[6].

Focusing on Symptom Management

Currently, there are no FDA-approved medications that cure or slow the progression of FTD itself ^[1]. Instead, care focuses on symptom management and improving daily quality of life ^[1][2].

• Non-pharmacological care: This is often the first line of defense, including establishing routines, adapting the home environment, caregiver education, speech therapy, and safety planning ^[1].
• Off-label medications: While standard dementia drugs are not used, doctors may prescribe other medications off-label (using a drug for an unapproved indication) to help manage specific symptoms. For example, certain antidepressants (like SSRIs or trazodone) may be used to target depression, anxiety, irritability, or compulsive behaviors ^[7][1].

What to Do If You Are Already Taking These Medications

Because early FTD symptoms can overlap with Alzheimer’s disease, it is very common for patients to be prescribed an Alzheimer’s medication before receiving a specific FTD diagnosis. A change in diagnosis does not mean a mistake was made, as diagnostic uncertainty is common in the early stages and mixed pathologies can occur ^[8].

If you are currently taking donepezil, rivastigmine, galantamine, or memantine, do not stop taking it on your own. Always consult your prescriber. Depending on the specific medication, dosage, and your personal health profile, your doctor will create an individualized plan to either safely taper off or stop the medication while monitoring you for any changes in behavior or function.